Literature DB >> 3707176

Lupus erythematosus panniculitis with partial genetic deficiency of C2 and C4 in a child.

A Taïeb, J P Hehunstre, J Goetz, J E Surlève Bazeille, D Fizet, G Hauptmann, J Maleville.   

Abstract

A 7-year-old girl developed recurrent febrile nodules and subcutaneous plaques on her arm, shoulder, and face. Primary acquired toxoplasmosis was diagnosed at onset, because of associated lymphadenopathy and detection of specific IgM. Skin lesions were responsive to therapy with systemic steroids but progressed to atrophy and poikiloderma within a few months. Subsequently, chloroquine therapy has been instituted and no relapse has occurred. Histopathologic findings and direct immunofluorescence studies were diagnostic of lupus erythematosus panniculitis. Electron microscopy showed lamellar inclusions within mast cells. Results of laboratory investigations disclosed leukopenia and hypocomplementemia with low C2 serum levels. A family study of the complement system, including C4 and Bf phenotyping and HLA A, B, and DR haplotyping, revealed the carriage of both C2 and C4A null alleles in the propositus. This observation suggests an additional link between lupus erythematosus panniculitis and the remainder of the lupus erythematosus clinical spectrum.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3707176     DOI: 10.1001/archderm.1986.01660170106030

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  3 in total

1.  Update on management of connective tissue panniculitides.

Authors:  Inbal Braunstein; Victoria P Werth
Journal:  Dermatol Ther       Date:  2012 Mar-Apr       Impact factor: 2.851

2.  Combined heterozygous deficiency of the classical complement pathway proteins C2 and C4.

Authors:  D Hartmann; V Fremeaux-Bacchi; L Weiss; A Meyer; J Blouin; G Hauptmann; M Kazatchkine; B Uring-Lambert
Journal:  J Clin Immunol       Date:  1997-03       Impact factor: 8.317

3.  Lupus erythematosus panniculitis: an immunohistochemical study.

Authors:  V Riccieri; A Sili Scavalli; A Spadaro; E Taccari; A Zoppini
Journal:  Clin Rheumatol       Date:  1994-12       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.